i
GENOME EDITING IN HUMAN CELLS USING CRISPR/CAS NUCLEASES
-
Oct 01 2015
Source: Curr Protoc Mol Biol. 112:31.3.1-31.318. -
Alternative Title:Curr Protoc Mol Biol
-
Personal Author:
-
Description:The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system has been broadly adopted for highly efficient genome editing in a variety of model organisms and human cell types. Unlike previous genome editing technologies such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), CRISPR/Cas technology does not require complex protein engineering and can be utilized by any researcher proficient in basic molecular biology and cell culture techniques. This unit describes protocols for design and cloning of vectors expressing single or multiplex gRNAs, for transient transfection of human cell lines, and for quantitation of mutation frequencies by T7 endonuclease I assay. These protocols also include guidance for using two improvements that increase the specificity of CRISPR/Cas nucleases: truncated gRNAs and dimeric RNA-guided FokI nucleases.
-
Subjects:
-
Pubmed ID:26423589
-
Pubmed Central ID:PMC4852847
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
-
jpeg jpeg bin gif jpeg gif jpeg gif jpeg jpeg
Details:
Supporting Files
More +